6533b82bfe1ef96bd128d8bc

RESEARCH PRODUCT

Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines.

Brigitte JanninM. Cherkaoui MalkiNorbert LatruffeDominique Delmas

subject

HepatoblastomaCancer Researchendocrine system diseasesCell SurvivalCellMitosisResveratrolBiologyPharmacologychemistry.chemical_compoundLiver Neoplasms ExperimentalStilbenesmedicineTumor Cells CulturedAnimalsHumansMitosisCell growthorganic chemicalsCell CycleLiver Neoplasmsfood and beveragesGeneral MedicineCell cycleAntineoplastic Agents PhytogenicCell biologyRatsmedicine.anatomical_structureOncologychemistryApoptosisCell cultureResveratrolHepatic stellate cellCell Division

description

Resveratrol is a polyphenolic compound especially produced by grapevine and consequently found in wine. Based on epidemiological studies resveratrol may act as a cancer chemopreventive compound. The ability of resveratrol to inhibit cell proliferation was studied in rat hepatoma Fao cell line and human hepatoblastoma HepG2 cell line. The results show that resveratrol strongly inhibits cell proliferation at the micromolar range in a time- and dose-dependent manner. Concentrations higher than 50 microM become toxic. Fao cells are more sensitive than HepG2 cells. Interestingly, the presence of ethanol lowers the threshold of resveratrol effect. Resveratrol appears to prevent or to delay the entry to mitosis since no inhibition of [3H]thymidine incorporation is observed, while there is an increase of cell number in S and G2/M phases. In conclusion, resveratrol shows a strong inhibition of hepatic cell proliferation where alcohol may act as an enhancing agent.

10.3892/or.7.4.847https://pubmed.ncbi.nlm.nih.gov/10854556